safety and effectiveness of chest wall high-frequency oscillation versus traditional chest physiotherapy in patients with bronchiectasis

Safety and effectiveness of treatment with chest wall high-frequency oscillation (HFCWO) versus chest physiotherapy in patients with bronchiectasis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002134

Enrollment

Unknown

Registered

2012-04-29

Start date

2012-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchiectasis

Interventions

A:chest wall high-frequency oscillation (HFCWO)

B:chest physiotherapy

Eligibility

Sex/Gender

Male

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients aged from 18 to 90 with bronchiectasis,producing at least 20 ml sputum / day for 3 consecutive daysand with stable clinical picture (no need for change in medical therapy during the previous week at enrollment).

Exclusion criteria

Exclusion criteria: Presence of tracheostomy, mechanical ventilation, severe abnormalities' of the sensory changes of chest radiography, severe cardiac arrhythmias or instability' dynamic; The criteria for drop-out are: lack of informed consent, clinical worsening, and the occurrence of one or more of the exclusion criteria.

Design outcomes

Primary

Measure	Time frame
improvement of respiratory functional test and blood chemistry and the amount of sputum (ml);	—

Secondary

Measure	Time frame
improving the quality of life( dyspnea scale (MMRC, CAT);	—

Countries

Italy

Contacts

Public ContactNicolini Antonello

antonello.nicolini@fastwebnet.it+39 0 185329145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 23, 2026